MDS expert Rafael Bejar, MD, PhD, shares how the type of genetic mutation present in MDS can make an
allogeneic stem cell transplant, or
bone marrow transplant, more desirable – for example, in high-risk
myelodysplastic syndromes (
MDS). Knowing which genetic mutations are present can also help doctors and patients decide if alternatives such as experimental therapies or
myelodysplastic syndromes (
MDS) are better options if the mutation makes relapse more likely.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.